The diagnosis of autism spectrum disorder (ASD) at the earliest age possible is important for initiating optimally effective intervention. Patients can be reliably diagnosed through behavioral testing at about 2 years of age. However, in the United States the average age of diagnosis is around 4 years. Identifying metabolic biomarkersignatures of ASD from blood samples offers an opportunity for developing earlier diagnostic tests.
Presented at the International Society for Autism Research (INSAR) Annual Meeting in Rotterdam, Netherlands; May 2018. NeuroPointDX’s autism